A little reading for you
@goedy@smellyfingers There is quite a bit more to consider lol!
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182334/#sec-a.g.ctitle
"
Colon cancer biomarkersCurrently, the concept of biomarkers, or biological markers, is more fluid and is continually being updated. According to the current clinical standards, measuring the biomarkers for CRC should be
cheap and easy to identify cancer, should be able to find out the prognosis of the disease, and should predict the response to a certain treatment, which subsequently improves the patient’s prognosis and quality of life. During the early stages of colorectal carcinogenesis,
epigenetic modifications tend to occur more often than genetic mutations, indicating that they may be more useful as the next generation of diagnostic biomarkers for the identification of colonic polyps and malignancies [68]."
Epigenetic changes (e.g. DNA methylation) influence the production of proteins in cells. Colostat tests these proteins!
